Literature DB >> 19169657

From furless to heartless-unraveling the diverse functions of cathepsin L.

Friedrich C Luft1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19169657     DOI: 10.1007/s00109-009-0438-3

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


× No keyword cloud information.
  8 in total

1.  Cathepsin L deficiency as molecular defect of furless: hyperproliferation of keratinocytes and pertubation of hair follicle cycling.

Authors:  W Roth; J Deussing; V A Botchkarev; M Pauly-Evers; P Saftig; A Hafner; P Schmidt; W Schmahl; J Scherer; I Anton-Lamprecht; K Von Figura; R Paus; C Peters
Journal:  FASEB J       Date:  2000-10       Impact factor: 5.191

2.  Lysosomal, cytoskeletal, and metabolic alterations in cardiomyopathy of cathepsin L knockout mice.

Authors:  Ivonne Petermann; Christian Mayer; Jörg Stypmann; Martin L Biniossek; Desmond J Tobin; Markus A Engelen; Thomas Dandekar; Tilman Grune; Lorenz Schild; Christoph Peters; Thomas Reinheckel
Journal:  FASEB J       Date:  2006-04-24       Impact factor: 5.191

3.  Decreased apoptosis in polyamine depleted IEC-6 cells depends on Akt-mediated NF-kappaB activation but not GSK3beta activity.

Authors:  S Bhattacharya; R M Ray; L R Johnson
Journal:  Apoptosis       Date:  2005-08       Impact factor: 4.677

4.  Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L.

Authors:  Jörg Stypmann; Kerstin Gläser; Wera Roth; Desmond J Tobin; Ivonne Petermann; Rainer Matthias; Gerold Mönnig; Wilhelm Haverkamp; Günter Breithardt; Wolfgang Schmahl; Christoph Peters; Thomas Reinheckel
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

Review 5.  Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.

Authors:  P H Sugden; S J Fuller; S C Weiss; A Clerk
Journal:  Br J Pharmacol       Date:  2008-01-21       Impact factor: 8.739

6.  Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.

Authors:  Qizhu Tang; Jun Cai; Difei Shen; Zhouyan Bian; Ling Yan; You-Xin Wang; Jie Lan; Guo-Qing Zhuang; Wen-Zhan Ma; Wei Wang
Journal:  J Mol Med (Berl)       Date:  2008-12-19       Impact factor: 4.599

7.  Cell type-specific functions of the lysosomal protease cathepsin L in the heart.

Authors:  Daniel Spira; Jörg Stypmann; Desmond J Tobin; Ivonne Petermann; Christian Mayer; Sascha Hagemann; Olga Vasiljeva; Thomas Günther; Roland Schüle; Christoph Peters; Thomas Reinheckel
Journal:  J Biol Chem       Date:  2007-10-17       Impact factor: 5.157

8.  Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage.

Authors:  Norbert Henke; Ruth Schmidt-Ullrich; Ralf Dechend; Joon-Keun Park; Fatimunnisa Qadri; Maren Wellner; Michael Obst; Volkmar Gross; Rainer Dietz; Friedrich C Luft; Claus Scheidereit; Dominik N Muller
Journal:  Circ Res       Date:  2007-06-21       Impact factor: 17.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.